ProShare Advisors’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

ProShare Advisors’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-28,128	Closed	-$421K	–	1572
2016 Q2	$421K	Buy	28,128 +599	+2%	+$7.7K	0.01%	1044
2016 Q1	$335K	Sell	27,529 -2,654	-9%	-$37.2K	﹤0.01%	1156
2015 Q4	$480K	Buy	30,183 +2,691	+10%	+$42.4K	0.01%	1052
2015 Q3	$421K	Sell	27,492 -1,353	-5%	-$29.2K	0.01%	990
2015 Q2	$701K	Sell	28,845 -1,702	-6%	-$40.8K	0.01%	943
2015 Q1	$710K	Buy	30,547 +4,154	+16%	+$110K	0.01%	1018
2014 Q4	$663K	Buy	26,393 +702	+3%	+$20.6K	0.01%	1074
2014 Q3	$799K	Sell	25,691 -4,292	-14%	-$116K	0.01%	1157
2014 Q2	$775K	Sell	29,983 -13,394	-31%	-$297K	0.01%	1301
2014 Q1	$1.01M	Buy	43,377 +28,042	+183%	+$613K	0.01%	1300
2013 Q4	$389K	Buy	15,335 +4,794	+45%	+$108K	0.01%	1102
2013 Q3	$215K	Buy	+10,541	New	+$235K	0.01%	2147

ProShare Advisors's SGNT Position: Q3 2016 in Review

ProShare Advisors sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 28,128 shares — an estimated $421K sold.

ProShare Advisors first reported a position in SGNT in Q3 2013 and held it in 12 quarters. The position peaked at $1.01M in Q1 2014. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

ProShare Advisors reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
ProShare Advisors sold 28,128 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $421K.
ProShare Advisors first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2013 and held it in 12 quarters.
ProShare Advisors's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $1.01M in Q1 2014.
0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on ProShare Advisors's 13F filing for Q3 2016, filed 10 Nov 2016.